Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: IM-862 in Treating Patients With Recurrent Ovarian Cancer [Phase 1]
Phase 1 trial evaluating IM-862 in patients with recurrent ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic Cancer
A completed clinical trial comparing epidural analgesia versus patient-controlled analgesia for gynecologic cancer surgery, with conditions …
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors [Phase 1]
A completed Phase 1 study evaluating the safety and tolerability of U3-1565 in patients with advanced solid tumors and advanced ovarian canc…
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 2]
A Phase 2 trial evaluating the combination of Bevacizumab and Erlotinib in patients with recurrent or metastatic ovarian epithelial cancer, …
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: Topotecan Weekly Versus Topotecan Day 1-5 in Patient With Platin-resistant Ovarian Cancer [Phase 2]
Phase 2 trial comparing weekly topotecan to a day 1-5 dosing schedule in platinum-resistant ovarian cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 safety, efficacy, and pharmacokinetic study of siltuximab in patients with various solid tumors has been completed, including ov…
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Ovarian Cancer [Phase 2]
Phase 2 trial evaluating Globo H-KLH immunotherapy in women with non-progressive ovarian cancer; the current status of the study is not repo…
-
CLINICAL_TRIALS trial_result · 2014-04-16Clinical Trial Update: Guilford Genomic Medicine Initiative (GGMI)
The Guilford Genomic Medicine Initiative trial has completed (status: COMPLETED). The conditions listed for the study include breast cancer,…
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 update on a veliparib, oxaliplatin, and capecitabine combination in patients with advanced solid tumors. The study, including pancre…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery [Phase 1]
Phase 1 study evaluating AFP464 in patients with metastatic or unresectable solid tumors completed; the trial enrolled patients with various…
-
CLINICAL_TRIALS trial_result · 2014-02-14Clinical Trial Update: Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
A Phase 2 trial evaluating pemetrexed disodium for ovarian cancer and primary peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-14Clinical Trial Update: Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating cetuximab in combination with carboplatin for recurrent ovarian epithelial cancer or primary peritoneal cancer; the…
-
CLINICAL_TRIALS trial_result · 2014-01-16Clinical Trial Update: Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer [Phase 2]
A Phase 2 study evaluating topotecan with erlotinib in topotecan-pretreated ovarian cancer was terminated; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse [Phase 3]
Phase 3 trial comparing Caelyx (liposomal doxorubicin) plus carboplatin with paclitaxel plus carboplatin in late-relapsed epithelial ovarian…
-
CLINICAL_TRIALS trial_result · 2014-01-08Clinical Trial Update: Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer [Phase 1]
Phase 1 study evaluating lenalidomide (Revlimid) in combination with pegylated liposomal doxorubicin (Doxil) and bevacizumab (Avastin) in pl…
-
CLINICAL_TRIALS trial_result · 2014-01-07Clinical Trial Update: Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating a chemo-immunotherapy regimen of gemcitabine, interferon-alpha 2b, and p53 SLP in platinum-resistant recurrent …
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
This Phase 2 clinical trial update describes a study of docetaxel plus carboplatin for patients with Stage III or IV ovarian, fallopian tube…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma [Phase 2]
This update covers a Phase 2 trial of temozolomide in advanced soft tissue sarcoma. The trial listing also notes related conditions of endom…
-
CLINICAL_TRIALS trial_result · 2014-01-03Clinical Trial Update: A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer [Phase 2]
Phase II study evaluating the combination of docetaxel and carboplatin in late-relapse ovarian cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial evaluating pazopanib monotherapy as a second-line treatment after first-line chemotherapy in ovarian, fallopian tube, or prima…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: CP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Phase 2]
A Phase 2 study evaluating CP-547,632 in recurrent or persistent ovarian cancer, fallopian tube cancer, and primary peritoneal cancer has co…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer [Phase 3]
A Phase 3 clinical trial comparing carboplatin plus paclitaxel versus carboplatin plus docetaxel in ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Screening Women at High Genetic Risk for Ovarian Cancer [NA]
The clinical trial evaluating screening for ovarian cancer in women at high genetic risk has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles [Phase 2]
Phase 2 trial evaluating enoxaparin thromboprophylaxis in cancer patients with elevated tissue factor-bearing microparticles has completed w…
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Eribulin Mesylate in Treating Patients With Recurrent Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating eribulin mesylate in patients with recurrent ovarian epithelial cancer, fallopian tube cancer, or primary peritonea…